Infosys sets Nov 14 as record date for its Rs 18,000 crore buyback at Rs 1,800/share. Check eligibility and tender…
GIFT Nifty and global markets open lower amid mixed cues in oil, gold, and currency trends. Track the latest movements…
Track key stocks like LIC, Infosys, and Lupin after their latest results and major announcements—get the latest market movers now!
Pine Labs launches its Rs 3,900 crore IPO with a price band of Rs 210-221.
Discover Nuvama’s top 3 Buy stock picks—Adani Ports, Motherson Sumi, VRL Logistics—with up to 44% upside; explore their investment rationale…
Markets today at close, November 06: Indian markets closed lower with major indices in the red; explore top gainers and…
Morgan Stanley’s latest call on Adani Power sparks investor buzz 17% upside on robust PPAs, low leverage, and Rs 2.25…
Pine Labs IPO opens Nov 7 with a Rs 3,900 crore issue—explore financials, objectives, and subscription details before you invest!
Hindalco shares fall 7% after Nuvama downgrades to ‘Hold’ over margin pressures and fire impact; learn what investors should watch…
Track big midday movers like Asian Paints, Hindalco, IndiGo, Paytm and more, see which stocks are soaring or sliding today!
Asian Paints shares jump 6% on MSCI weight increase and competitor CEO exit—track the latest stock movements now!
PhysicsWallah IPO opens Nov 11, aims to raise Rs 3,480 crore – learn key details and consider investing now!
Global giant Goldman Sachs backs India’s market rally, from Titan to Reliance, here are six stocks it says could surge…
Discover why Nuvama raises Grasim’s price target despite Q2 slip—see the paint business outlook and investment insights now.
Markets today at open, November 06: Indian equity indices open subdued as markets eye US Supreme Court developments on Trump…
MSCI adds 4 new stocks and removes 2 from India Standard Index in November rebalancing. See full list and prepare…
NSE introduces pre-open session for F&O to boost price discovery and cut volatility—see how it can impact your trading strategy…
Motilal Oswal has given Gland Pharma a ‘Buy’ rating with a Rs 2,310 target price, implying a 17% upside. The…